Updated:
China Summit Capital
China Summit Capital is a private equity fund management organization focused on life science and technology investments. They have made 10 investments to...
China Summit Capital
China Summit Capital is a private equity fund management organization focused on life science and technology investments. They have made 10 investments to date. Their most recent investment was in Impact Therapeutics as part of their Series D funding on March 14, 2022.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Shanghai
Corporate office
Shanghai, China
Sector focus
Frequently asked questions
Who runs investment decisions at China Summit Capital?
No named principals or investment committee members appear in the available records.
What asset classes does China Summit Capital deploy into?
The firm lists early-stage seed, start-up, expansion, late-stage, and general venture strategies.
Does China Summit Capital participate in fund commitments or direct deals?
No information on fund structure, co-investments, or SPVs is present in the sources.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: